• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者糖尿病视网膜病变的四年发病率及其进展的影响因素

Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes.

作者信息

Manaviat M R, Rashidi M, Afkhami-Ardekani M

机构信息

Diabetes Research Center, Yazd, Iran.

出版信息

Eur J Ophthalmol. 2008 Jul-Aug;18(4):572-7. doi: 10.1177/112067210801800412.

DOI:10.1177/112067210801800412
PMID:18609477
Abstract

PURPOSE

To study the 4 years incidence of diabetic retinopathy in patients with type II diabetes and effective factors on its progression.

METHODS

Among diabetic patients referred to Yazd Diabetes Research Center, 120 patients with type II diabetes without diabetic retinopathy were selected. After complete ophthalmic examination, fasting blood sugar (FBS), postprandial blood sugar, triglyceride, and cholesterol were measured and height, weight, and blood pressure (BP) were recorded. Then patients were followed with eye examination yearly for 4 years.

RESULTS

Four-year cumulative incidence of diabetic retinopathy was 47.5% (95% CI: 38.6-56.4). The retinopathy was mild nonproliferative diabetic retinopathy (NPDR) in 43 (35.8%) whereas 10 (8.3%) patients had moderate NPDR, 3 (2.5%) patients had severe NPDR, and only one patient had proliferative diabetic retinopathy. The incidence of diabetic retinopathy was 5.8% in first year, 20.3% in the second year, 24.4% in the third year, and 7.4% in the fourth year. Duration of diabetes, FBS, and systolic BP had statistically significant relation with grades of diabetic retinopathy. However, there was no significant association between age, sex, body mass index, triglyceride, cholesterol, method of treatment, smoking, and diastolic BP with grades of diabetic retinopathy.

CONCLUSIONS

These data provide 4-year cumulative incidence of diabetic retinopathy in defined type 2 diabetic patients. The present study shows that duration of diabetes, hyperglycemia, and systolic BP appear to be the major factors associated with the development of any level of retinopathy in type 2 diabetic patients.

摘要

目的

研究2型糖尿病患者糖尿病视网膜病变的4年发病率及其进展的影响因素。

方法

在转诊至亚兹德糖尿病研究中心的糖尿病患者中,选取120例无糖尿病视网膜病变的2型糖尿病患者。在完成眼科检查后,测量空腹血糖(FBS)、餐后血糖、甘油三酯和胆固醇,并记录身高、体重和血压(BP)。然后对患者进行为期4年的每年一次的眼科检查随访。

结果

糖尿病视网膜病变的4年累积发病率为47.5%(95%可信区间:38.6 - 56.4)。视网膜病变为轻度非增殖性糖尿病视网膜病变(NPDR)的有43例(35.8%),而10例(8.3%)患者为中度NPDR,3例(2.5%)患者为重度NPDR,只有1例患者为增殖性糖尿病视网膜病变。糖尿病视网膜病变的发病率在第一年为5.8%,第二年为20.3%,第三年为24.4%,第四年为7.4%。糖尿病病程、FBS和收缩压与糖尿病视网膜病变的分级有统计学显著关系。然而,年龄、性别、体重指数、甘油三酯、胆固醇、治疗方法、吸烟和舒张压与糖尿病视网膜病变的分级之间无显著关联。

结论

这些数据提供了特定2型糖尿病患者糖尿病视网膜病变的4年累积发病率。本研究表明,糖尿病病程、高血糖和收缩压似乎是2型糖尿病患者发生任何程度视网膜病变的主要相关因素。

相似文献

1
Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes.2型糖尿病患者糖尿病视网膜病变的四年发病率及其进展的影响因素
Eur J Ophthalmol. 2008 Jul-Aug;18(4):572-7. doi: 10.1177/112067210801800412.
2
First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.葡萄牙糖尿病视网膜病变的首次发病和进展研究,RETNODIAB 研究:里斯本地区筛查计划的评估。
Ophthalmology. 2015 Dec;122(12):2473-81. doi: 10.1016/j.ophtha.2015.08.004. Epub 2015 Sep 15.
3
Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study.特定老年人群中糖尿病视网膜病变的五年发病率及病情进展:蓝山眼研究
Eye (Lond). 2007 Apr;21(4):465-71. doi: 10.1038/sj.eye.6702771. Epub 2007 Feb 23.
4
Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes.2型糖尿病患者收缩压的就诊间变异性可预测糖尿病肾病的发生和进展,但不能预测视网膜病变。
J Diabetes Complications. 2014 Mar-Apr;28(2):185-90. doi: 10.1016/j.jdiacomp.2013.11.003. Epub 2013 Nov 13.
5
Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran.伊朗伊斯法罕糖尿病视网膜病变的发病率及危险因素
Ophthalmic Epidemiol. 2003 Apr;10(2):81-95. doi: 10.1076/opep.10.2.81.13893.
6
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.意大利东北部长达十年的糖尿病视网膜病变远程医疗筛查项目。
J Diabetes Complications. 2017 Aug;31(8):1348-1353. doi: 10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13.
7
Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study.糖尿病视网膜病变的六年发病率及病情进展:毛里求斯糖尿病并发症研究结果
Diabetes Res Clin Pract. 2006 Sep;73(3):298-303. doi: 10.1016/j.diabres.2006.02.009. Epub 2006 Apr 3.
8
Development and progression of diabetic retinopathy in Koreans with NIDDM.韩国非胰岛素依赖型糖尿病患者糖尿病视网膜病变的发生与进展
Diabetes Care. 1998 Jan;21(1):134-8. doi: 10.2337/diacare.21.1.134.
9
The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.1型糖尿病患者动态血压和脉搏率与视网膜病变的关系:肾素-血管紧张素系统研究
Ophthalmology. 2006 Dec;113(12):2231-6. doi: 10.1016/j.ophtha.2006.06.003. Epub 2006 Sep 25.
10
Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study.重度非增殖性/增殖性糖尿病视网膜病变的发病率及危险因素:德黑兰血脂与血糖研究的十余年随访
J Diabetes Investig. 2022 Feb;13(2):317-327. doi: 10.1111/jdi.13647. Epub 2021 Sep 13.

引用本文的文献

1
Assessing the possible association between MTHFR (rs1801133) and GPx-1 (rs1050450) polymorphisms with the risk of type 2 diabetes, diabetic neuropathy, and diabetic retinopathy.评估 MTHFR(rs1801133)和 GPx-1(rs1050450)多态性与 2 型糖尿病、糖尿病神经病变和糖尿病视网膜病变风险之间的可能关联。
Mol Biol Rep. 2024 Apr 29;51(1):583. doi: 10.1007/s11033-024-09519-0.
2
Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.2 型糖尿病患者血脂异常与糖尿病视网膜病变的关系:系统评价和荟萃分析。
Syst Rev. 2023 Aug 24;12(1):148. doi: 10.1186/s13643-023-02321-2.
3
Factors Associated with Fluctuations in Central Subfield Thickness in Patients with Diabetic Macular Edema Using Diabetic Retinopathy Clinical Research Protocols T and V.
使用糖尿病视网膜病变临床研究方案T和V的糖尿病性黄斑水肿患者中央子域厚度波动的相关因素
Ophthalmol Sci. 2022 Sep 23;3(1):100226. doi: 10.1016/j.xops.2022.100226. eCollection 2023 Mar.
4
Diabetic retinopathy in the Eastern Morocco: Different stage frequencies and associated risk factors.摩洛哥东部的糖尿病视网膜病变:不同阶段的频率及相关危险因素
Saudi J Biol Sci. 2021 Jan;28(1):775-784. doi: 10.1016/j.sjbs.2020.11.010. Epub 2020 Nov 11.
5
Prevalence, Incidence and Ecological Determinants of Diabetic Retinopathy in Iran: Systematic Review and Meta-analysis.伊朗糖尿病视网膜病变的患病率、发病率及生态决定因素:系统评价与荟萃分析
J Ophthalmic Vis Res. 2019 Jul 18;14(3):321-335. doi: 10.18502/jovr.v14i3.4790. eCollection 2019 Jul-Sep.
6
Association between lipid accumulation product and diabetic retinopathy based on a community-based survey in Chinese with type 2 diabetes.基于中国2型糖尿病社区调查的脂质蓄积产物与糖尿病视网膜病变的关联
Diabetes Metab Syndr Obes. 2019 Apr 16;12:513-518. doi: 10.2147/DMSO.S195578. eCollection 2019.
7
Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis.血脂异常与糖尿病视网膜病变之间的关系:一项系统评价与荟萃分析。
Medicine (Baltimore). 2018 Sep;97(36):e12283. doi: 10.1097/MD.0000000000012283.
8
Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review.体重指数与糖尿病视网膜病变风险:一项荟萃分析和系统评价
Medicine (Baltimore). 2017 Jun;96(22):e6754. doi: 10.1097/MD.0000000000006754.
9
The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board.泪液功能障碍的正确诊断与治疗管理:P.I.C.A.S.S.O.委员会的建议
Int Ophthalmol. 2018 Apr;38(2):875-895. doi: 10.1007/s10792-017-0524-4. Epub 2017 Apr 10.
10
Determining the Prevalence of Retinopathy and Its Related Factors among Patients with Type 2 Diabetes in Kerman, Iran.确定伊朗克尔曼2型糖尿病患者视网膜病变的患病率及其相关因素。
Osong Public Health Res Perspect. 2016 Oct;7(5):296-300. doi: 10.1016/j.phrp.2016.08.004. Epub 2016 Aug 24.